Personas / Equipo Humano

Jordi Antón López

Buscador de publicaciones

Publicaciones

  • Foeldvari I, Solebo A, Angeles-Han ST, Brost AG, de Boer J, Días-Cascajosa J, Glerup M, Ingels H, Klotsche J, Koopman-Kalinina Ayuso V, Maccora I, Mata S, Nordal E, Ruperto N, Simonini G, Swart JF, Titz J, van Meerwij CLLI and Anton-Lopez J.

    What is the best way to plan a 12-month clinical drug trial in JIA associated uveitis?

    Expert Review of Clinical Immunology . 22(3): 323-336.

    [doi:10.1080/1744666X.2026.2659684]

  • Foell D, Jelusic M, Sag E, Consolaro A, Poelzl M and Anton-Lopez J.

    Paediatric rheumatology care in Europe: setting children and adolescents into focus

    Lancet Rheumatology . 8(5): 401-405.

    [doi:10.1016/S2665-9913(25)00378-9]

  • Mastrolia MV, Pandiarajan V, Cattalini M, Taddio A, Vergnano S, Anton-Lopez J, Sontichai W, Sozeri B, Ozen S, Rosina S, Sánchez-Manubens J, Haviv R, Pal P, Fonseca AR, Gagro A, Bagri NK, Verdoni L, Montin D, Maggio MC, Thangaraj A, Pilania R, Mosquera-Angarita JM, Calzada-Hernández J, Sittiwangkul R, Ulu K, Balik Z, Bilginer Y, Garrone M, Patrone E, Barbi E, Ciacci G, Barucci A, Ruperto N and Simonini G.

    Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study.

    EClinicalMedicine . 93: 103813-103813.

    [doi:10.1016/j.eclinm.2026.103813]

  • Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton-Lopez J, Bini I, Clemente D, Correia M, Costello W, De Cock D, Domjan A, Leon L, Marques A, Minden K, Mourão AF, Najm A, Özen S, Pimentel G, Saleem Z, Vetrovsky T, Wulffraat N, Zacarias A, Prior Y, Carmona L and Estévez-López F.

    Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care.

    ANNALS OF THE RHEUMATIC DISEASES . 84(12): 2115-2127.

    [doi:10.1016/j.ard.2025.01.017]

  • Israni M, Alderson E, Mahlaoui N, Obici L, Rossi-Semerano L, Lachmann H, Avramovic MZ, Guffroy A, Dalm V, Rimmer R, Solis L, Villar C, Gennery AR, Skeffington S, Nordin J, Warnatz K, Korganow AS, Anton-Lopez J, Cattalini M, Berg S, Soler-Palacin P, Campbell M and Burns SO.

    Recommendations for Transitioning Young People with Primary Immunodeficiency Disorders and Autoinflammatory Diseases to Adult Care

    JOURNAL OF CLINICAL IMMUNOLOGY . 45(1): 57-57. Nº de citas: 3

    [doi:10.1007/s10875-024-01838-y]

  • Quesada-Masachs E, de Inocencio J, Nieto González JC, Monteagudo Sáez I, Murias Loza S, Medrano San Ildefonso M, Calzada-Hernández J, Calvo Penadés I, Galindo Zabala R, Lopez Corbeto M and Anton-Lopez J.

    Cervical spine arthritis as initial manifestation in Juvenile Idiopathic Arthritis: a multicenter retrospective study.

    Pediatric Rheumatology . 23(1): 111-111.

    [doi:10.1186/s12969-025-01161-9]

  • Simonini G, Anton-Lopez J, Horneff G, Berard R and Belot A.

    Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach.

    EXPERT OPINION ON BIOLOGICAL THERAPY . 25(11): 1193-1211.

    [doi:10.1080/14712598.2025.2577752]

  • Foeldvari I, Solebo A, Petrushkin H, Angeles-Han ST, Bangsgaard R, Calzada-Hernández J, Constantin T, de Boer J, Días-Cascajosa J, Glerup M, Ingels H, Kramer S, Miserocchi E, Nordal E, Saurenmann RK, Simonini G, Swart JF, Titz J and Anton-Lopez J.

    Monitoring of Juvenile Idiopathic Arthritis-Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood.

    ARTHRITIS CARE & RESEARCH . 77(9): 1106-1111. Nº de citas: 1

    [doi:10.1002/acr.25542]

  • Anton-Lopez J, Montoro M, Loza E, Otón T, Ramirez S and Benavent D.

    Digital health tools in juvenile idiopathic arthritis: a systematic literature review.

    Pediatric Rheumatology . 23(1): 45-45. Nº de citas: 1

    [doi:10.1186/s12969-025-01094-3]

  • Bustaffa M, Bella S, Bayindir Y, Amaryan G, Gallizzi R, Papadopoulou-Alataki E, Fabio G, Assalia N, Amarilyo G, Bakkaloglu S, Jesenak M, Breda L, Anton-Lopez J, Legger E, Alessio M, Simonini G, Rigante D, Obici L, Kuemmerle-Deschner J, Kasapcopur O, Insalaco A, Glerup M, Frenkel J, Brunner J, Horneff G, Sánchez-Manubens J, Cantarini L, Spagnolo A, Alataki S, Carrabba M, Belder N, Porreca A, Caorsi R, Ruperto N, Gattorno M and Ozen S.

    Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study.

    JOURNAL OF AUTOIMMUNITY . 153: 103421-103421. Nº de citas: 3

    [doi:10.1016/j.jaut.2025.103421]